| |
|
|
|
|
|
|
|||
|
PA Patston, RL Medcalf, Y Kourteva and M Schapira
Department of Medicine, Vanderbilt University, Nashville, TN 37232.
The biosynthesis of the serpin alpha 1-proteinase inhibitor is regulated by
a feedback mechanism whereby complexes between alpha 1- proteinase
inhibitor and serine proteinases bind to liver cells and monocytes, a
reaction that activates alpha 1-proteinase-inhibitor gene transcription.
Such a mechanism may form the basis for the development of new therapeutic
strategies for serpin deficiency states with reduced levels of otherwise
normally functioning serpins. This issue was addressed for C1-inhibitor,
the missing serpin in hereditary angioedema. C1-inhibitor biosynthesis by
Hep G2 hepatoma cells was assessed by enzyme-linked immunosorbant assay, by
metabolic labeling followed by immunoprecipitation, and by Northern
blotting. C1-inhibitor biosynthesis was stimulated by gamma-interferon (100
U/mL) but not by cell exposure to C1-inhibitor-kallikrein (1 mumol/L),
C1-inhibitor-C1s (1 mumol/L), and C1-inhibitor-plasmin complexes (1
mumol/L) or to reactive site-cleaved C1-inhibitor (1 mumol/L). Moreover,
radioiodinated C1s-C1-inhibitor complex did not bind to Hep G2 cells.
C1-inhibitor-kallikrein complex was also without effect on C1-inhibitor
mRNA in U 937 cells. Therefore, the proposed mechanism, by which serpin-
enzyme complex or reactive site-cleaved serpin binding to a specific
receptor provides a signal for the stimulation of the biosynthesis of that
serpin, is not operative for the biosynthesis of C1-inhibitor by Hep G2 or
U 937 cells.
This article has been cited by other articles:
| ||||||||||
| Copyright © 1993 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||